WO2012007776A3 - Disinfectant and antiseptic formulation having reduced iodine content - Google Patents

Disinfectant and antiseptic formulation having reduced iodine content Download PDF

Info

Publication number
WO2012007776A3
WO2012007776A3 PCT/HU2011/000065 HU2011000065W WO2012007776A3 WO 2012007776 A3 WO2012007776 A3 WO 2012007776A3 HU 2011000065 W HU2011000065 W HU 2011000065W WO 2012007776 A3 WO2012007776 A3 WO 2012007776A3
Authority
WO
WIPO (PCT)
Prior art keywords
disinfectant
iodine content
antiseptic formulation
reduced iodine
antiseptic
Prior art date
Application number
PCT/HU2011/000065
Other languages
French (fr)
Other versions
WO2012007776A2 (en
Inventor
Endre Mikulásik
Tamás SPAITS
Original Assignee
Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság filed Critical Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság
Priority to UAA201301371A priority Critical patent/UA109144C2/en
Priority to EA201390090A priority patent/EA022847B1/en
Priority to EP11751629.4A priority patent/EP2592935A2/en
Priority to BR112013000690A priority patent/BR112013000690A2/en
Publication of WO2012007776A2 publication Critical patent/WO2012007776A2/en
Publication of WO2012007776A3 publication Critical patent/WO2012007776A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12—Iodine, e.g. iodophors; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cleaning By Liquid Or Steam (AREA)

Abstract

The invention is related to the use of the solution of elemental iodine prepared in an organosiloxane solvent as antiseptic or disinfectant agent and formulations suitable for such use.
PCT/HU2011/000065 2010-07-12 2011-07-12 Disinfectant and antiseptic formulation having reduced iodine content WO2012007776A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
UAA201301371A UA109144C2 (en) 2010-07-12 2011-07-12 Disinfectant and antiseptic agent with lowered iodine content
EA201390090A EA022847B1 (en) 2010-07-12 2011-07-12 Disinfectant and antiseptic formulation having reduced iodine content
EP11751629.4A EP2592935A2 (en) 2010-07-12 2011-07-12 Disinfectant and antiseptic formulation having reduced iodine content
BR112013000690A BR112013000690A2 (en) 2010-07-12 2011-07-12 low iodine disinfectant and antiseptic formulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1000362A HUP1000362A2 (en) 2010-07-12 2010-07-12 Antiseptic and disinfecting compositions having reduced iodine content
HUP1000362 2010-07-12

Publications (2)

Publication Number Publication Date
WO2012007776A2 WO2012007776A2 (en) 2012-01-19
WO2012007776A3 true WO2012007776A3 (en) 2012-06-07

Family

ID=89989820

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HU2011/000065 WO2012007776A2 (en) 2010-07-12 2011-07-12 Disinfectant and antiseptic formulation having reduced iodine content

Country Status (11)

Country Link
EP (1) EP2592935A2 (en)
AR (1) AR082155A1 (en)
BR (1) BR112013000690A2 (en)
EA (1) EA022847B1 (en)
GE (1) GEP20156236B (en)
HK (1) HK1150373A2 (en)
HU (1) HUP1000362A2 (en)
TW (1) TW201216859A (en)
UA (1) UA109144C2 (en)
UY (1) UY33502A (en)
WO (1) WO2012007776A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012150891A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Composition for administration of a pharmacologically or cosmetically active agent onto a surface of a living organism
GB2521997A (en) 2013-09-06 2015-07-15 Biocompatibles Uk Ltd Radiopaque polymers
WO2016175728A1 (en) * 2015-04-27 2016-11-03 Aydin Kimya Sanayi Ve Ticaret Anonim Sirketi Production method for a pdms-i based antimicrobial solution
CA2990627A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
AU2018253944B2 (en) * 2017-04-21 2022-09-15 Dermaliq Therapeutics, Inc. Iodine compositions
US11723861B2 (en) 2017-09-27 2023-08-15 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
CA3111870C (en) 2018-09-27 2022-04-12 Novaliq Gmbh Topical sunscreen formulation
CN112755050B (en) * 2020-12-31 2022-11-15 佛山市正典生物技术有限公司 Alcohol-free iodine-containing disinfectant with high component stability and preparation method thereof
CN114208818B (en) * 2021-11-09 2022-10-04 佛山市正典生物技术有限公司 Iodine-containing disinfectant containing polyol ether and/or cyclic ether and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4738956A (en) * 1984-02-06 1988-04-19 Neutrogena Corporation Hydrocortisone composition having enhanced bioavailability and percutaneous absorption
US6024968A (en) * 1991-08-16 2000-02-15 Lincoln Technologies Inc. Intersorption composition and method
JP2006083119A (en) * 2004-09-17 2006-03-30 Mandom Corp Germicidal disinfectant composition
WO2006138035A1 (en) * 2005-06-13 2006-12-28 Dow Corning Corporation Vehicle for the delivery of topical lipid soluble pharmaceutical agents
US20070036731A1 (en) * 2005-08-13 2007-02-15 Collegium Pharmaceutical, Inc. Topical Delivery with a Carrier Fluid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081232A (en) * 1960-12-27 1963-03-12 Warner Lambert Pharmaceutical Iodine preparation and method of disinfecting the skin
FR2611733B1 (en) 1987-02-26 1989-06-16 Rhone Poulenc Chimie IODINE-CONTAINING DIORGANOPOLYSILOXANE GUM COMPOSITION FOR WATER TREATMENT
FR2611735B1 (en) 1987-02-26 1989-06-16 Rhone Poulenc Chimie IODINE-CONTAINING SILICONE POLYADDITION ELASTOMER COMPOSITION FOR WATER TREATMENT
FR2611734B1 (en) 1987-02-26 1989-06-16 Rhone Poulenc Chimie IODINE-CONTAINING SILICONE POLYCONDENSATION ELASTOMER COMPOSITION FOR WATER TREATMENT
FR2634772A1 (en) 1988-07-29 1990-02-02 Rhone Poulenc Chimie IODINE-CONTAINING DIORGANOPOLYSILOXANE OIL-BASED COMPOSITION FOR WATER TREATMENT
FR2648143B1 (en) 1989-06-08 1991-09-06 Rhone Poulenc Chimie COMPOSITION COMPRISING A THERMOPLASTIC SILICONE COPOLYMER AND AN IODINE COMPOUND FOR USE IN WATER TREATMENT
DE19837850C1 (en) 1998-08-20 2000-01-05 Wacker Chemie Gmbh Organosiloxane mixture useful as volatile carrier in cosmetic formulations

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4738956A (en) * 1984-02-06 1988-04-19 Neutrogena Corporation Hydrocortisone composition having enhanced bioavailability and percutaneous absorption
US6024968A (en) * 1991-08-16 2000-02-15 Lincoln Technologies Inc. Intersorption composition and method
JP2006083119A (en) * 2004-09-17 2006-03-30 Mandom Corp Germicidal disinfectant composition
WO2006138035A1 (en) * 2005-06-13 2006-12-28 Dow Corning Corporation Vehicle for the delivery of topical lipid soluble pharmaceutical agents
US20070036731A1 (en) * 2005-08-13 2007-02-15 Collegium Pharmaceutical, Inc. Topical Delivery with a Carrier Fluid

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALFRED J DISAPIO: "Silicones as Alternatives to Hydrocarbons in Personal Care Formulations", DOW CORNING PUBLICATIONS, 1 January 1993 (1993-01-01), USA, pages 1 - 6, XP055023872, Retrieved from the Internet <URL:http://www.dowcorning.com.cn/zh_CN/content/publishedlit/25-528-93.pdf> [retrieved on 20120404] *
HISAHIKO WATANABE ET AL: "DETERMINATION OF SOLUBILITY PARAMETER FOR SILOXANE SEGMENT - THE SOLUBILITY OF IODINE IN LIQUID POLYDIMETHYLSILOXANE", JOURNAL OF CHEMICAL ENGINEERING OF JAPAN, vol. 6, no. 2, 15 June 1973 (1973-06-15), pages 109 - 114, XP055023868, DOI: 10.1252/jcej.6.109 *
KOZO SHINODA ET AL, THE JOURNAL OF PHYSICAL CHEMISTRY, vol. 61, no. 6, 1 June 1957 (1957-06-01), pages 789 - 791, XP055023870, ISSN: 0022-3654, DOI: 10.1021/j150552a022 *
MORAIN W.D., VISTNES L.M.: "Iodinated silicone-an antibacterial alloplastic material", PLAST. RECONSTR. SURG., vol. 59, no. 2, 1 February 1977 (1977-02-01), USA, pages 216 - 222, XP009158172 *

Also Published As

Publication number Publication date
UY33502A (en) 2012-01-31
HK1150373A2 (en) 2011-12-16
EP2592935A2 (en) 2013-05-22
WO2012007776A2 (en) 2012-01-19
BR112013000690A2 (en) 2016-05-17
AR082155A1 (en) 2012-11-14
HUP1000362A2 (en) 2012-11-28
HU1000362D0 (en) 2010-10-28
UA109144C2 (en) 2015-07-27
GEP20156236B (en) 2015-01-26
EA022847B1 (en) 2016-03-31
EA201390090A1 (en) 2013-05-30
TW201216859A (en) 2012-05-01

Similar Documents

Publication Publication Date Title
WO2012007776A3 (en) Disinfectant and antiseptic formulation having reduced iodine content
MX343583B (en) Thioacetate compounds, compositions and methods of use.
WO2012055567A3 (en) Use of malononitrilamides in neuropathic pain
WO2011107186A3 (en) Compounds for electronic devices
WO2011159840A3 (en) Phenylthioacetate compounds, compositions and methods of use
MX2013002932A (en) Liquid agricultural formulations of improved stability.
MY162146A (en) Pharmaceutical composition
MX2012013606A (en) Tamarind seed polysaccharide for use in the treatment of microbial infections.
WO2011161396A3 (en) Disinfectant composition
EP2249823A4 (en) Octanoic acid formulations and methods of treatment using the same
WO2009024374A3 (en) Novel dipolar ionic compounds comprising formulations and the use thereof
WO2010039654A3 (en) Topical treatment of skin infection
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
MX359713B (en) Improved wound healing compositions comprising microspheres.
WO2012054695A8 (en) Antimicrobial amphiphiles and methods for their use
WO2011076840A3 (en) Aerosol formulation for copd
MX355668B (en) Use of a myrtle extract as an anti-biofilm agent against p. acnes.
WO2011139249A3 (en) Pharmaceutical composition comprising cefdinir
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
EP2885345B8 (en) Azeotropic and azeotrope-like compositions of 2,3,3,4,4,4-hexafluoro-1-butene and 1,1,1,2,3,3-hexafluoropropane and uses thereof
EP2543374A4 (en) Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient
WO2011034514A3 (en) Stable micronized granules having high solubility
MX2012012324A (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males.
MX358798B (en) Flavor and fragrance formulation (v).
WO2011124861A3 (en) Use of xanthan-derived oligosaccharide compounds as energizing agent

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2011751629

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011751629

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 201390090

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 12995

Country of ref document: GE

WWE Wipo information: entry into national phase

Ref document number: A201301371

Country of ref document: UA

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11751629

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013000690

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013000690

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130110